产品名称 | NebuSelect™ Recombinant Human Kremen-2, His-tag |
---|---|
目录号 | NBL-240849 |
别名 | Kremen-2; KRM2; KREMEN2; Kremen-2; Dickkopf receptor 2 |
外观 | see COA |
分子量 | Gly26-Ala364 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8NCW0-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240849-100ug | 100ug | Inquire | Inquire | |
NBL-240849-1mg | 1mg | Inquire | Inquire | |
NBL-240849-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Kremen-2, His-tag
Catalog#:
NBL-240849
Description:
NebuSelect™ Recombinant Human Kremen-2, His-tag(Cat#NBL-240849) is expressed in HEK293 with His tag at the C-Terminus.It contains Gly26-Ala364.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 37.1 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
Kremen-2; KRM2; KREMEN2; Kremen-2; Dickkopf receptor 2
Target Information:
Kremen2 (Krm2) plays an important role in embryonic development, bone formation, and tumorigenesis as a crucial regulator of classical Wnt/β-catenin signaling pathway. Compared to para-cancerous tissues, Krm2 was significantly up-regulated in gastric cancer tissues and was positively correlated with the pathological grade of gastric cancer patients. Krm2 can be a potent candidate for designing of targeted therapy.
Amino Acid Sequence:
Gly26-Ala364
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.